-
Qin L, Marrs G, McKim R, Dailey M. Hippocampal mossy fibers induce assembly and clustering of PSD95-containing postsynaptic densities independent of glutamate receptor activation. The Journal of Comparative Neurology 2001, 440:284-298.[PubMed Abstract]
- Qin LX, Kerr KF, Contributing Members of the Toxicogenomics Research Consortium. Empirical evaluation of data transformations and ranking statistics for microarray analysis. Nucleic Acids Research 2004, 32:5471-5479.[PubMed Abstract]
- Members of the Toxicogenomics Research Consortium. Standardizing global gene expression analysis between laboratories and across platforms. Nature Methods 2005, 2:351-356. [PubMed Abstract]
- Qin LX, Beyer R, Hudson N, Linford N, Morris D, Kerr KF. Evaluation of methods for oligonucleotide array data via quantitative real-time PCR. BMC Bioinformatics 2006, 7:23.[PubMed Abstract]
- Qin LX and Self SG. The clustering of regression models method with applications to gene expression data. Biometrics 2006, 62: 526-533.[PubMed Abstract]
- Canter RJ, Qin LX, Downey R, Brennan MF, Singer S, Maki RG. Perioperative chemotherapy in patients undergoing pulmonary resection for metastasis soft tissue sarcoma of the extremity. Cancer 2007, 110:2050-2060. [PubMed Abstract]
- Qin LX. An Integrative Analysis of microRNA and mRNA Expression - A Case Study. Cancer Informatics 2008, 6:369-379. [PubMed Abstract]
- Al-Ahmadie HA, Alden D, Qin LX, Olgac S, Fine SW, Gopalan A, Russo P, Motzer RJ, Reuter VE, Tickoo SK. Carbonic anhydrase IX expression in clear cell renal cell carcinoma: an immunohistochemical study comparing two antibodies. American Journal of Surgical Pathology 2008, 32:377-382. [PubMed Abstract]
- Forslund A, Zeng A, Qin LX, Rosenberg S, Ndubuisi M, Pincas H, Gerald W, Notterman D, Barany F, Paty PB. MDM2 gene amplification is correlated to tumor progression but not to presence of SNP309 or TP53 mutational status in primary colorectal cancers. Molecular Cancer Research 2008, 6:205-211.[PubMed Abstract]
- Ambrosini G, Seelman SL, Qin LX, Schwartz GK. The cyclin-dependent kinase inhibitor flavopiridol potentiates the effects of topoisomerase I poisons by suppressing Rad51 expression in a p53-dependent manner. Cancer Research 2008, 68:2312-2320.[PubMed Abstract]
- The Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008, 455:1061-1068.[PubMed Abstract]
- Canter RJ, Qin LX, Moraco N, Dalal KM, Maki RG, Brennan MF, Ladanyi M, Singer S. A synovial sarcoma specific preoperative nomogram supports a survival benefit to Ifosfamide-based chemotherapy and improves risk stratification for patients. Clinical Cancer Research 2008, 14:8191-8197.[PubMed Abstract]
- Canter RJ, Qin LX, Ferrone CR, Maki RG, Singer S, Brennan MF. Why do patients with low grade sarcoma die? Annals of Surgical Oncology 2008, 15:3550-3560.[PubMed Abstract]
- Meng RD, Shelton CC, Li YM, Qin LX, Notterman D, Paty PB, Schwartz GK. Gamma-secretase inhibitors abrogate Oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity. Cancer Research 2009, 69:573-582.[PubMed Abstract]
- Kushner BH, Kramer K, Modak S, Qin LX, Yataghena K, Jhanwar SC, and Cheung NKV. Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastoma. Pediatric Blood & Cancer 2009, 53:17-22.[PubMed Abstract]
- Qin LX and Satagopan J. Normalization method for transcriptional studies of heterogeneous samples - simultaneous array normalization and identification of equivalent expression. Statistical Applications in Genetics and Molecular Biology 2009, 8: Article 10.[PubMed Abstract]
- Jhawer M, Coit D, Brennan M, Qin LX, Gonen M, Klimstra D, Tang L, Kelsen DP, Shah MA. Perineural invasion following preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation. American Journal of Clinical Oncology. [PubMed Abstract]
- Maki RG, D'Adamo DR, Keohan ML, Saulle M, Schuetze SM, Undevia SD, Livingston MB, Cooney MM, Hensley ML, Mita MM, Takimoto CH, Kraft AS, Elias AD, Brockstein B, Blachère NE, Edgar MA, Schwartz LH, Qin LX, Antonescu CR, Schwartz GK. A phase II study of sorafenib in patients with metastatic or recurrent sarcomas. Journal of Clinical Oncology. [PubMed Abstract]
- Korkola JE, Houldsworth J, Feldman D, Olshen AB, Qin LX, Patil S, Reuter VE, Bosl GJ, Chaganti RSK. Outcome prediction in adult male germ cell tumor patients through expression profiling. Journal of Clinical Oncology in press.
|
